Machine learning-derived biomarker cutoffs for Alzheimer’s disease: Validation and application in preclinical and prodromal phases

Wei Wang(Capital Medical University), Meina Quan(Capital Medical University), Qi Wang(Anhui University), Shuo Xu(Nanjing University of Chinese Medicine), Shuangshuang Hou(Shandong University of Traditional Chinese Medicine), Tingting Li(Capital Medical University), Di Sun(Shandong University), Zhao Tan(Capital Medical University), Bo Wang(Yunnan University)
iScience
October 30, 2025
10.1016/j.isci.2025.113895
Cited by 0

Related Papers

Diphosphine-protected ultrasmall gold nanoclusters: opened icosahedral Au<sub>13</sub>and heart-shaped Au<sub>8</sub>clusters
|Chemical Science|2017|117
Tongue Coating Bacteria as a Potential Stable Biomarker for Gastric Cancer Independent of Lifestyle
|Digestive Diseases and Sciences|2020|65
Genetic Phenotypes of Alzheimer’s Disease: Mechanisms and Potential Therapy
|Phenomics|2023|50
Engineered Extracellular Vesicle-Based Nanoformulations That Coordinate Neuroinflammation and Immune Homeostasis, Enhancing Parkinson’s Disease Therapy
|ACS Nano|2024|45
Cascade-Type Microglial Pyroptosis Inhibitors for Enhanced Treatment of Cerebral Ischemia-Reperfusion Injury
|ACS Nano|2025|16